Advaxis Reports Preclinical Study of LM-LLO Immunotherapy Showed Tumor Eradication
June 04, 2014 at 08:04 AM EDT
Advaxis, Inc. (Nasdaq: ADXS), a biotechnology company developing cancer immunotherapies, announced the publication of preclinical ...